Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

SPN and Lung Cancer Adam J. Hayek, DO
SPN and Lung Cancer Adam J. Hayek, DO
by sequest
PGY-6. Pulmonary and Critical Care Fellow . GOALS....
Patient Selection for PARP
Patient Selection for PARP
by sherrill-nordquist
Inhibitors:. Purpose and Practicalities . Present...
The Role of Antiangiogenic Agents
The Role of Antiangiogenic Agents
by luanne-stotts
The Role of Antiangiogenic Agents in the Changin...
Ezra W Cohen University of California, San Diego
Ezra W Cohen University of California, San Diego
by natalia-silvester
Ezra W Cohen University of California, San Diego...
Michael A. Postow, MD
Michael A. Postow, MD
by kittie-lecroy
Michael A. Postow, MD Assistant Attending Physici...
CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data
CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data
by min-jolicoeur
CDK 4/6 Inhibitors in Breast Cance...
It takes more than milk to improve bone health!!
It takes more than milk to improve bone health!!
by aaron
Lawrence Drudge-Coates. Urological Oncology Clini...
ADVANCES IN THERAPY FOR SARCOMA AND GIST
ADVANCES IN THERAPY FOR SARCOMA AND GIST
by ellena-manuel
Angela . Cioffi. , MD. Sarcoma Research Program c...
Managing Advanced Renal Cell
Managing Advanced Renal Cell
by debby-jeon
Carcinoma: Balancing . Efficacy with Quality of L...
IMMUNOTHERAPY Group 6 Melinda Bachini, Thelma Brown, Jean Di Carlo-Wagner, Bob Riter, Chris Kinsing
IMMUNOTHERAPY Group 6 Melinda Bachini, Thelma Brown, Jean Di Carlo-Wagner, Bob Riter, Chris Kinsing
by conchita-marotz
IMMUNOTHERAPY. Preventative. Vaccines. HPV. Hepa...
19 th Annual NOCR Meeting
19 th Annual NOCR Meeting
by cheryl-pisano
Session I: Breast Cancer. Bone Directed Therapy ...
Cancer Unknown Primary Sarah W. Gordon, DO
Cancer Unknown Primary Sarah W. Gordon, DO
by olivia-moreira
Assistant Professor. Virginia Commonwealth Univer...
Sipuleucel -T Survival Benefit
Sipuleucel -T Survival Benefit
by calandra-battersby
Sipuleucel. -T was approved based on HR of 0.775 ...
Alexander Olinger , PharmD
Alexander Olinger , PharmD
by mitsue-stanley
PGY-2 Oncology Pharmacy Resident. Pharmacy Grand...
EGFR-Mutated Advanced NSCLC
EGFR-Mutated Advanced NSCLC
by sherrill-nordquist
The Coming Paradigm Shift. Faculty. Suresh S. Ram...
Andrew H. Ko, MD University of California San Francisco
Andrew H. Ko, MD University of California San Francisco
by test
Gastrointestinal Oncology Program. Treatment of m...
Fellows Lecture CRC & Anal Cancer
Fellows Lecture CRC & Anal Cancer
by liane-varnes
Treatment of CRC by Stage. Colon cancer. Stage I:...
James L. Gulley M.D. , Ph.D.,
James L. Gulley M.D. , Ph.D.,
by tatyana-admore
F.A.C.P. .. Head, Immunotherapy Section. Chief, G...
Supplemental Figure 1. Mutation frequencies in adenocarcinoma of the lung
Supplemental Figure 1. Mutation frequencies in adenocarcinoma of the lung
by giovanna-bartolotta
Data source: . Wang R, Pan Y, Li C, et al. Analys...
Antiangiogenic Agents in Advanced NSCLC
Antiangiogenic Agents in Advanced NSCLC
by ellena-manuel
Jared Weiss, MD . Assistant . Professor of Medici...
Jon Trent, MD, PhD Professor of Medicine
Jon Trent, MD, PhD Professor of Medicine
by jane-oiler
Sarcoma . Medical Oncology. The University of . M...
Where we are with targeted
Where we are with targeted
by stefany-barnette
therapies . for . cholangiocarcinoma. Professor J...
T o Starve Cancer to Death!
T o Starve Cancer to Death!
by tatiana-dople
——. The Anti-angiogenesis . E. ffects in the ...
Thomas E. Keane
Thomas E. Keane
by danika-pritchard
Medical University of South Carolina . Charleston...
Testicular and
Testicular and
by pamella-moone
E. xtragonadal. Germ . C. ell . T. umors: Focus ...
William J.
William J.
by tawny-fly
Gradishar. . MD, FACP. Betsy . Bramsen. Profess...
Second line
Second line
by alida-meadow
treatments. in WT . pts. : . which. . opportuni...
Metastatic HER2-Positive Breast Cancer: Treatment Selection
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
Toxicities of Radiation Therapy in Cancer
Toxicities of Radiation Therapy in Cancer
by natalia-silvester
Bradley . Burton, . PharmD. , BCOP, . CACP. Septe...
Mechanisms of resistance to EGFR
Mechanisms of resistance to EGFR
by conchita-marotz
TKI. s. . and . related. . treatment . strategi...
than one vitreous specimens to yield the diagnosis. Measurements of le
than one vitreous specimens to yield the diagnosis. Measurements of le
by debby-jeon
lymphoma. J Clin Oncol, 10: 635-643, 1992. 5. De S...
Managing Breast Cancer in the Genomic Era
Managing Breast Cancer in the Genomic Era
by alida-meadow
Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...
6th Annual Interdisciplinary
6th Annual Interdisciplinary
by giovanna-bartolotta
Prostate Cancer . Congress. Meeting in . a. Box....
Il trattamento
Il trattamento
by alida-meadow
del carcinoma . della. . prostata. in . fase. ...
17th Annual International Congress
17th Annual International Congress
by conchita-marotz
on . Hematologic Malignancies. ®. : . Focus . on...
Recurrent Follicular Lymphoma
Recurrent Follicular Lymphoma
by sherrill-nordquist
With a Short First Remission:. How Aggressive Sho...
Michael
Michael
by luanne-stotts
Brada. . Torino. . 6 March 2015. Perspectives...
Please note, these are the actual video-recorded proceeding
Please note, these are the actual video-recorded proceeding
by lindy-dunigan
Moderator. Neil Love, MD. Jessica Mitchell, RN, C...
Chee Lee,
Chee Lee,
by olivia-moreira
MBBS (Hons), . MMedSci. (. Clin. . Epid. ), . M...
ASCO Update 2012:
ASCO Update 2012:
by tatyana-admore
Gastrointestinal Malignancies. Thomas J. Semrad M...